-
Head and Neck Cancer
3004984
global
1
1.0
9
1.0
2
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-03-09 19:00:00
Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Melanoma
65
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-08 19:00:00
Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Lung Cancer
5000186
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-02-27 19:00:00
Do you know the latest information on immunotherapy for the management of non-small cell lung cancer (NSCLC)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Aesthetic Medicine
5000574
global
1
0.5
2
0.5
0.5
Roundtable
0
1
General Surgery2023-02-26 19:00:00
Chemical peeling can yield great results in skin rejuvenation; our experts explain what you need to know to start peeling in your own practice.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Biologic Therapy
5000033
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-02-22 19:00:00
Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Glioblastoma
1541
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-02-21 19:00:00
A 65-year-old patient, John, presents with rapid, progressive left-sided weakness. You suspect glioblastoma. What would you do next?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Head and Neck Cancer
3004984
global
1
1.0
9
1.0
2
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-03-09 19:00:00
Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Melanoma
65
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-08 19:00:00
Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Lung Cancer
5000186
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-02-27 19:00:00
Do you know the latest information on immunotherapy for the management of non-small cell lung cancer (NSCLC)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Aesthetic Medicine
5000574
global
1
0.5
2
0.5
0.5
Roundtable
0
1
General Surgery2023-02-26 19:00:00
Chemical peeling can yield great results in skin rejuvenation; our experts explain what you need to know to start peeling in your own practice.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Biologic Therapy
5000033
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-02-22 19:00:00
Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Glioblastoma
1541
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-02-21 19:00:00
A 65-year-old patient, John, presents with rapid, progressive left-sided weakness. You suspect glioblastoma. What would you do next?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Thromboembolism
63912
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-02-08 19:00:00
Confront the challenges of treating cancer-associated thromboembolism (CAT): learn about the utility of factor XI, current and emerging data, and implications for improved patient care.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-01-29 19:00:00
Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Thromboembolism
63912
global
1
0.25
9
0.25
0.25
Commentary
0
1
Cardiology2023-01-19 19:00:00
Learn more about venous thromboembolism (VTE) prevention strategies as patients transition to the post-hospital setting.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Melanoma
65
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-01-12 19:00:00
Did you know that melanoma has more somatic mutations than any other cancer type?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Heart Failure (HF)
64646
global
1
2.5
9
2.5
2
2.5
2.5
Roundtable
0
1
Cardiology2023-01-03 19:00:00
There are so many new options for the treatment of heart failure. Are you up to date?
2.5ABIM MOC
2.5CME/CE
150MIN
Save
-
0
global
1
1.0
9
1.0
3
1.0
1.0
Clinical Case
0
1
Infectious Diseases2023-01-03 19:00:00
Are you current on CMV management in the transplant patient?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Cardiac Surgery
6005128
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Nephrology2023-01-03 19:00:00
Acute kidney injury after cardiac surgery is common but potentially reversible. Listen as our experts discuss strategies to prevent and mitigate risk.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Cardiovascular Risk Management
3029460
global
1
2.5
9
2.5
2
2.5
2.5
Roundtable
0
1
Cardiology2022-12-29 19:00:00
A multi-targeted and interprofessional approach to lower the risk of CV events.
2.5ABIM MOC
2.5CME/CE
150MIN
Save
-
Acute Coronary Syndrome
5000359
global
1
1.5
9
1.5
2
1.5
1.5
Roundtable
0
1
Cardiology2022-12-29 19:00:00
What are the most up-to-date treatment strategies? Expert faculty discuss.
1.5ABIM MOC
1.5CME/CE
90MIN
Save
-
0
global
1
1.0
9
1.0
2
1.0
1.0
Clinical Case
0
1
Gastroenterology2022-12-13 19:00:00
Choose your own SBS treatment paths in this interactive, engaging clinical simulation
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Peripheral Artery Disease
419
global
1
0.25
9
0.25
0.25
Commentary
0
1
Cardiology2022-12-11 19:00:00
Improve outcomes in post-revascularization patients with peripheral artery disease (PAD). Integrate the latest data for using dual antithrombotic therapy.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Hematology-Oncology2022-12-08 19:00:00
Join this discussion to hear our experts discuss the management of human epidermal growth factor receptor 2 (HER2)-positive breast cancer across multiple lines of therapy.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
